AMANDA CHRISTOPHER THOMAS: Open Payments
NPI 1558734137 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,476 in 201 payments from 33 companies in 2025. Trend: 2023 $3,575 · 2024 $3,420 · 2025 $3,476
Food & beverage: $3,476
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 59 | $884 |
| PFIZER INC. | 17 | $241 |
| Novo Nordisk Inc | 12 | $237 |
| AstraZeneca Pharmaceuticals LP | 11 | $203 |
| Otsuka America Pharmaceutical, Inc. | 11 | $190 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 16 | $176 |
| Sumitomo Pharma America, Inc. | 7 | $167 |
| Axsome Therapeutics, Inc. | 10 | $163 |
| GlaxoSmithKline, LLC. | 9 | $149 |
| Lilly USA, LLC | 7 | $134 |
Products named: VRAYLAR, REXULTI, Wegovy, NURTEC ODT, GEMTESA, JARDIANCE, XIFAXAN, TRELEGY ELLIPTA.
Industry payments across NC — which companies pay providers there.
